Olympus Partners collects two-thirds of Accelevation's $540 million IPO
Accelevation's $540 million Nasdaq IPO sends $360 million to private equity backer Olympus Partners and $180 million to the company, before underwriting fees. The company's share is slated to repay debt and cover the costs of the listing, with general corporate purposes listed last.
The Investor · Invest desk
What happened
- Olympus-affiliated holders also gave underwriters a 30-day option to buy up to 4.5 million more shares at $18, less underwriting discounts and commissions.
- ACCV shares are due to start trading on the Nasdaq Global Select Market on September 30, 2026, with the offering expected to close on October 1.
- Accelevation, based in Miamisburg, Ohio, designs, manufactures and installs custom structural, electrical and mechanical systems for mission-critical infrastructure.
- Olympus, founded in 1988, is a middle-market buyout firm managing more than $12 billion, mostly for pension funds, endowments and state-sponsored retirement programs.
Why it matters
- What it costs cost With the option fully exercised, public buyers would hand Olympus's affiliates about $2.45 for every $1 of gross proceeds that reaches Accelevation.
- Who's exposed exposure Price risk on the 20 million shares Olympus's affiliates sell passes from a fund run for pension funds and endowments to public buyers paying $18.
- What it limits constraint Growth spending at a manufacturer with nationwide field crews gets only what is left of $180 million after discounts, debt repayment and listing costs are paid.
Next story · Invest · 17h ago
General Atlantic targets a first-half 2027 IPO valued at up to $10 billionConfirmed3 publishers
At $18 a share, $12 of every share sold in the base deal goes to stockholders affiliated with Olympus Partners and $6 goes to Accelevation [14]. The split follows the share count: 20 million of the 30 million shares are Olympus's and 10 million are new [5], and the company gets nothing from the shares its backer sells [6]. Even the $6 is gross, struck before underwriting discounts, commissions and other expenses [1]. Ten banks hold bookrunner roles, led by Morgan Stanley and J.P. Morgan [4][13].
The overallotment option can move that split in only one direction. All 4.5 million extra shares would come from the selling stockholders [7], so full exercise adds $81 million [8] and lifts the Olympus side to $441 million of $621 million, about 71% [15]. Accelevation's $180 million stays fixed, and its share of the money raised slips from a third to about 29% [16].
The company's portion, or rather what survives the underwriting discount, takes a short route. Accelevation will buy newly issued units in Accelevation Holdings LLC with its net proceeds [9]. The LLC will spend the money repaying indebtedness, covering the costs of the IPO and related organizational transactions, and on general corporate purposes [10]. The pricing report does not give amounts for those uses or a post-offering share count [12].
This reading is too harsh if the debt being repaid is expensive. Retiring costly debt helps every holder, buyers at $18 included [1]. It is also too harsh if Olympus still owns a large stake after selling its 20 million shares [5]. In that case the $360 million is a first instalment, and the value of what Olympus keeps depends on the ACCV price as much as any new holder's stake does [5][2].
I think the base case is the plain one. The deal turns two-thirds of a $540 million offering into cash for a private equity backer [14] and hands the company a sum that goes first to its lenders and to the costs of listing [10]. A post-offering ownership table showing Olympus still in control would change that view. ACCV would then be a partial float with its controlling owner still inside, a different security to price at $18 [1].
What to watch
- Whether underwriters take up all 4.5 million option shares within 30 days of pricing, lifting Olympus's cut from two-thirds to about 71%.
- Final prospectus figures for how much debt Accelevation Holdings LLC repays and how much of the company Olympus owns after the October 1 closing.
- How ACCV trades against its $18 offer price after its September 30 Nasdaq debut.
Information, not investment advice. This story is general information about companies and markets, drawn from cited reporting. It is not a recommendation to buy, sell or hold any security; check the cited sources before acting.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence80
- Adoption45
- Hype gap+10
- Incentives75
- Confidence75
Perspective Coverage
3 publishers- Builder
- Builder 10%
- Operator
- Operator 18%
- Investor
- Investor 72%
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Accelevation Holdings priced its IPO of 30 million Class A shares at $18 each, a gross offering value of $540 million before underwriting discounts, commissions and other expenses.
- [2]
Accelevation shares are expected to begin trading on the Nasdaq Global Select Market on September 30, 2026, under the ticker ACCV; the offering is expected to close on October 1, 2026.
- [3]
Accelevation, headquartered in Miamisburg, Ohio, designs, manufactures and installs customized structural, electrical and mechanical systems for mission-critical infrastructure, combining U.S.-based manufacturing with nationwide field services.
- [4]
Morgan Stanley and J.P. Morgan are joint lead bookrunning managers; Goldman Sachs, Barclays and BofA Securities are joint bookrunning managers; Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are additional bookrunners.
- [5]
Accelevation is selling 10 million shares, about $180 million in gross proceeds to the company; stockholders affiliated with Olympus Partners are selling 20 million shares, about $360 million at the IPO price.
- [6]
Accelevation will not receive proceeds from shares sold by the selling stockholders.
- [7]
The selling stockholders granted the underwriters a 30-day option to buy up to 4.5 million additional shares at $18 per share, less underwriting discounts and commissions.
- [8]
If the option is exercised in full, it would add $81 million to the transaction and raise the total shares sold in the offering to 34.5 million.
- [9]
Accelevation plans to use the net proceeds it receives from the IPO to purchase newly issued units in Accelevation Holdings LLC.
- [10]
Accelevation Holdings LLC will use the proceeds to repay indebtedness, cover expenses associated with the IPO and related organizational transactions, and support general corporate purposes.
- [11]
Olympus Partners is a private equity firm focused on middle-market management buyouts and growth companies, founded in 1988, managing more than $12 billion primarily for pension funds, endowments and state-sponsored retirement programs.
- [12]
The pulse2 report of the pricing does not state amounts for the individual uses of proceeds or the number of shares outstanding after the offering.
- [13]
Ten banks hold bookrunner roles on the offering.
- [14]
Olympus-affiliated holders sell two-thirds of the base offering, so of each $18 share sold, $12 goes to Olympus affiliates and $6 to Accelevation, gross.
- [15]
With the option fully exercised, Olympus affiliates would receive about $441 million of $621 million in gross proceeds, about 71%.
- [16]
Accelevation's share of gross proceeds falls from about a third to about 29% if the option is fully exercised.
- [17]
With full option exercise, Olympus affiliates receive about $2.45 in gross proceeds for every $1 that reaches Accelevation.
Sources
3 independent publishers whose own reporting we read for this story.
- economictimes.indiatimes.comAccelevation IPO: AI infra firm Accelevation, shareholders raise $540 million in US IPO - The Economic Times
1 article · September 29, 2026
- globenewswire.comAccelevation Announces Pricing of Initial Public Offering
1 article · September 29, 2026
- pulse2.comAccelevation Prices $540 Million IPO At $18 Per Share
1 article · September 30, 2026
Topics and entities
Entities
- JP Morgan
- Renaissance Capital
- NASDAQ Global Select Market
- Morgan Stanley
- Olympus Partners
- Accelevation Holdings